Huber, C. Et Al. 2010. OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels. Human Mutation , vol.31, no.1 , 20-26.

Huber, C., Fradin, M., Edouard, T., Le Merrer, M., Alanay, Y., Da Silva, D. B., ... David, A.(2010). OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels. Human Mutation , vol.31, no.1, 20-26.

Huber, Celine Et Al. "OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels," Human Mutation , vol.31, no.1, 20-26, 2010

Huber, Celine Et Al. "OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels." Human Mutation , vol.31, no.1, pp.20-26, 2010

Huber, C. Et Al. (2010) . "OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels." Human Mutation , vol.31, no.1, pp.20-26.

@article{article, author={Celine Huber Et Al. }, title={OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels}, journal={Human Mutation}, year=2010, pages={20-26} }